NIH-funded research NIH-funded research

Research on safe practices for handling infectious diseases

Official title: BSL-3 Practices Core

Funded at George Mason University · NIH-10910213 · Data updated 2026-11-12

This study is all about making sure that scientists can safely work in labs to learn more about new infectious diseases, so they can quickly help us be ready for pandemics or bioterrorism, while also keeping everyone safe.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionGeorge Mason University
NIH-funded
Lab location1 site (Fairfax, United States)
Project startAugust 18, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$345,533
NIH project number5UC7AI180261-02
Project IDNIH-10910213 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include healthcare professionals and researchers involved in infectious disease management and response.

Less likely to help

Patients with non-infectious diseases or those not involved in healthcare or research may not receive direct benefits from this research.

What this research studies

This research focuses on establishing and maintaining safe practices in a high-containment laboratory environment to study emerging infectious diseases. It aims to enhance pandemic preparedness and ensure a rapid response to bioterrorism or other infectious disease emergencies. The project involves training personnel, operating advanced instrumentation, and generating reliable data to support the development of diagnostics, therapeutics, and vaccines. By adhering to strict federal regulations, the research ensures the safety of laboratory workers and the surrounding community.

Why it matters

Potential benefit: If successful, this research could lead to improved safety protocols and faster development of treatments and vaccines for infectious diseases.

How similar studies have gone: Previous research in high-containment laboratory practices has shown success in improving safety and efficacy in handling infectious pathogens.

Where this research is happening

  • George Mason University
    Fairfax, United States
    Active

Researchers

  • Principal investigator: Alem, Farhang — George Mason University
  • Study coordinator: Alem, Farhang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.